nach oben

Erschienen in:

14.06.2021 | Original Article

Identification of maternal continuous glucose monitoring metrics related to newborn birth weight in pregnant women with gestational diabetes

verfasst von: Song-Ying Shen, Justina Žurauskienė, Dong-Mei Wei, Nian-Nian Chen, Jin-Hua Lu, Ya-Shu Kuang, Hui-Hui Liu, Jean-Baptiste Cazier, Xiu Qiu

Erschienen in: Endocrine | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To identify the specific glucose metrics derived from maternal continuous glucose monitoring (CGM) data, which were associated with a higher percentile of offspring birth weight.

Methods

In this cohort study, we recruited singleton pregnant women with GDM who underwent CGM for 5–14 days at a mean of 28.8 gestational weeks between Jan 2017 and Nov 2018. Commonly used single summary glucose metrics of glucose exposure (including mean 24-h, daytime, and nighttime glucose level) and variability (including J-index and mean amplitude of glycaemic excursions) were derived from CGM data. A novel comprehensive glucose metric—hours per-day spent in a severe variability glucose mode (HSSV)—was identified using the spectral clustering method, which reflects both glucose level and variability. Multiple linear regression models were used to estimate the associations of sex- and gestational age-adjusted birth weight percentile with CGM parameters.

Results

Ninety-seven women comprising 127,279 glucose measurements were included. Each 1-SD increase in maternal nighttime mean glucose level and HSSV was associated with 6.0 (95% CI 0.4, 11.5) and 6.3 (95% CI 0.4, 12.2) percentage points increase in birth weight percentile, respectively. No associations were found between other glucose metrics and birth weight percentile.

Conclusion

Nighttime mean glucose level has a comparable effect size to HSSV in association with fetal growth, suggesting that endogenous hyperglycemia might drive the association between maternal hyperglycemia and birth weight. Further studies need to examine the effect of lowering nighttime glucose level and/or HSSV on preventing fetal overgrowth in GDM women.

Nur mit Berechtigung zugänglich

P.G. Ovesen, D.M. Jensen, P. Damm, S. Rasmussen, U.S. Kesmodel, Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes. a nation-wide study. J. Matern. Fetal Neonatal Med. 28, 1720–1724 (2015). https://doi.org/10.3109/14767058.2014.966677CrossRefPubMed

A. Fraser, D.A. Lawlor, Long-term health outcomes in offspring born to women with diabetes in pregnancy. Curr. Diabetes Rep. 14, 489 (2014). https://doi.org/10.1007/s11892-014-0489-xCrossRef

K. Kc, S. Shakya, H. Zhang, Gestational diabetes mellitus and macrosomia: a literature review. Ann. Nutr. Metab. 66(Suppl 2), 14–20 (2015). https://doi.org/10.1159/000371628CrossRefPubMed

X. Zhang, A. Decker, R.W. Platt, M.S. Kramer, How big is too big? The perinatal consequences of fetal macrosomia. Am. J. Obstet. Gynecol. 198, 517 e511–516 (2008). https://doi.org/10.1016/j.ajog.2007.12.005CrossRef

P. Damm, A. Houshmand-Oeregaard, L. Kelstrup, J. Lauenborg, E.R. Mathiesen, T.D. Clausen, Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia 59, 1396–1399 (2016). https://doi.org/10.1007/s00125-016-3985-5CrossRefPubMed

W.L. Lowe Jr, D.M. Scholtens, L.P. Lowe, A. Kuang, M. Nodzenski, O. Talbot, P.M. Catalano, B. Linder, W.J. Brickman, P. Clayton, C. Deerochanawong, J. Hamilton, J.L. Josefson, M. Lashley, J.M. Lawrence, Y. Lebenthal, R. Ma, M. Maresh, D. McCance, W.H. Tam, D.A. Sacks, A.R. Dyer, B.E. Metzger, Association of Gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA 320, 1005–1016 (2018). https://doi.org/10.1001/jama.2018.11628CrossRefPubMedPubMedCentral

American Diabetes Association, 13. Management of diabetes in pregnancy: standards of medical care in diabetes-2018. Diabetes Care 41, S137–S143 (2018). https://doi.org/10.2337/dc18-S013CrossRef

S. Shen, J. Lu, L. Zhang, J. He, W. Li, N. Chen, X. Wen, W. Xiao, M. Yuan, L. Qiu, K.K. Cheng, H. Xia, B.W.J. Mol, X. Qiu, Single fasting plasma glucose versus 75-g Oral Glucose-Tolerance Test in prediction of adverse perinatal outcomes: a cohort study. EBioMedicine 16, 284–291 (2017). https://doi.org/10.1016/j.ebiom.2017.01.025CrossRefPubMedPubMedCentral

M. Li, S.N. Hinkle, K.L. Grantz, S. Kim, J. Grewal, W.A. Grobman, D.W. Skupski, R.B. Newman, E.K. Chien, A. Sciscione, N. Zork, D.A. Wing, M. Nageotte, F. Tekola-Ayele, G.M.B. Louis, P.S. Albert, C. Zhang, Glycaemic status during pregnancy and longitudinal measures of fetal growth in a multi-racial US population: a prospective cohort study. Lancet Diabetes Endocrinol. 8, 292–300 (2020). https://doi.org/10.1016/S2213-8587(20)30024-3CrossRefPubMedPubMedCentral

10.

Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Group of Pregnancy with Diabetes Mellitus, Chinese Society of Perinatal Medicine, Chinese Medical Association., [Diagnosis and therapy guideline of pregnancy with diabetes mellitus]. Zhonghua Fu Chan Ke Za Zhi. 49, 561–569 (2014)

11.

M.P. Carreiro, A.I. Nogueira, A. Ribeiro-Oliveira, Controversies and advances in gestational diabetes-an update in the era of continuous glucose monitoring. J. Clin. Med. 7, E11 (2018). https://doi.org/10.3390/jcm7020011. piiCrossRefPubMed

12.

K. Cypryk, L. Bartyzel, M. Zurawska-Klis, W. Mlynarski, A. Szadkowska, J. Wilczynski, D. Nowakowska, L.A. Wozniak, W. Fendler, Continuous glucose monitoring in type 1 diabetes pregnancy shows that fetal heart rate correlates with maternal glycemia. Diabetes Technol. Ther. 17, 619–624 (2015). https://doi.org/10.1089/dia.2014.0255CrossRefPubMed

13.

B.M. Mulla, N. Noor, T. James-Todd, E. Isganaitis, T.C. Takoudes, A. Curran, C.E. Warren, K.E. O’Brien, F.M. Brown, Continuous glucose monitoring, glycemic variability, and excessive fetal growth in pregnancies complicated by type 1 diabetes. Diabetes Technol. Ther. 20, 413–419 (2018). https://doi.org/10.1089/dia.2017.0443CrossRefPubMedPubMedCentral

14.

J.B. Su, X.Q. Wang, J.F. Chen, G. Wu, Y. Jin, F. Xu, X.H. Wang, Y.T. Liu, Glycemic variability in gestational diabetes mellitus and its association with beta cell function. Endocrine 43, 370–375 (2013). https://doi.org/10.1007/s12020-012-9753-5CrossRefPubMed

15.

W.S. Panyakat, C. Phatihattakorn, A. Sriwijitkamol, P. Sunsaneevithayakul, A. Phaophan, A. Phichitkanka, Correlation between third trimester glycemic variability in non-insulin-dependent gestational diabetes mellitus and adverse pregnancy and fetal outcomes. J. Diabetes Sci. Technol. 12, 622–629 (2018). https://doi.org/10.1177/1932296817752374CrossRefPubMedPubMedCentral

16.

D. Naik, A. Hesarghatta Shyamasunder, M. Doddabelavangala Mruthyunjaya, R. Gupta Patil, T.V. Paul, F. Christina, M. Inbakumari, R. Jose, J. Lionel, A. Regi, P.V. Jeyaseelan, N. Thomas, Masked hypoglycemia in pregnancy. J. Diabetes. 9, 778–786 (2017). https://doi.org/10.1111/1753-0407.12485CrossRefPubMed

17.

F. Yu, L. Lv, Z. Liang, Y. Wang, J. Wen, X. Lin, Y. Zhou, C. Mai, J. Niu, Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study. J. Clin. Endocrinol. Metab. 99, 4674–4682 (2014). https://doi.org/10.1210/jc.2013-4332CrossRefPubMed

18.

G.R. Law, A. Alnaji, L. Alrefaii, D. Endersby, S.J. Cartland, S.G. Gilbey, P.E. Jennings, H.R. Murphy, E.M. Scott, Suboptimal nocturnal glucose control is associated with large for gestational age in treated gestational diabetes mellitus. Diabetes Care 42, 810–815 (2019). https://doi.org/10.2337/dc18-2212CrossRefPubMed

19.

R. Marquez-Pardo, I. Torres-Barea, J.A. Cordoba-Dona, C. Cruzado-Begines, L. Garcia-Garcia-Doncel, M. Aguilar-Diosdado, M.G. Baena-Nieto, Continuous glucose monitoring and glycemic patterns in pregnant women with gestational diabetes mellitus. Diabetes Technol. Ther. 22, 271–277 (2020). https://doi.org/10.1089/dia.2019.0319CrossRefPubMed

20.

H. Hall, D. Perelman, A. Breschi, P. Limcaoco, R. Kellogg, T. McLaughlin, M. Snyder, Glucotypes reveal new patterns of glucose dysregulation. PLoS Biol. 16, e2005143 (2018). https://doi.org/10.1371/journal.pbio.2005143CrossRefPubMedPubMedCentral

21.

B.E. Metzger, S.G. Gabbe, B. Persson, T.A. Buchanan, P.A. Catalano, P. Damm, A.R. Dyer, A. Leiva, M. Hod, J.L. Kitzmiler, L.P. Lowe, H.D. McIntyre, J.J. Oats, Y. Omori, M.I. Schmidt, International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33, 676–682 (2010). https://doi.org/10.2337/dc09-1848CrossRefPubMed

22.

G. Grothendieck, A. Zeileis, zoo: S3 infrastructure for regular and irregular time series. J. Stat. Software 14, 1–27 (2005).

23.

G.R. Law, G.T. Ellison, A.L. Secher, P. Damm, E.R. Mathiesen, R. Temple, H.R. Murphy, E.M. Scott, Analysis of continuous glucose monitoring in pregnant women with diabetes: distinct temporal patterns of glucose associated with large-for-gestational-age infants. Diabetes Care 38, 1319–1325 (2015). https://doi.org/10.2337/dc15-0070CrossRefPubMed

24.

D.S. Feig, L.E. Donovan, R. Corcoy, K.E. Murphy, S.A. Amiel, K.F. Hunt, E. Asztalos, J.F.R. Barrett, J.J. Sanchez, A. de Leiva, M. Hod, L. Jovanovic, E. Keely, R. McManus, E.K. Hutton, C.L. Meek, Z.A. Stewart, T. Wysocki, R. O’Brien, K. Ruedy, C. Kollman, G. Tomlinson, H.R. Murphy, Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 390, 2347–2359 (2017). https://doi.org/10.1016/S0140-6736(17)32400-5CrossRefPubMedPubMedCentral

25.

T.L. Hernandez, L.A. Barbour, A standard approach to continuous glucose monitor data in pregnancy for the study of fetal growth and infant outcomes. Diabetes Technol Ther. 15, 172–179 (2013). https://doi.org/10.1089/dia.2012.0223CrossRefPubMedPubMedCentral

26.

T. Battelino, T. Danne, R.M. Bergenstal, S.A. Amiel, R. Beck, T. Biester, E. Bosi, B.A. Buckingham, W.T. Cefalu, K.L. Close, C. Cobelli, E. Dassau, J.H. DeVries, K.C. Donaghue, K. Dovc, F.J. Doyle 3rd, S. Garg, G. Grunberger, S. Heller, L. Heinemann, I.B. Hirsch, R. Hovorka, W. Jia, O. Kordonouri, B. Kovatchev, A. Kowalski, L. Laffel, B. Levine, A. Mayorov, C. Mathieu, H.R. Murphy, R. Nimri, K. Norgaard, C.G. Parkin, E. Renard, D. Rodbard, B. Saboo, D. Schatz, K. Stoner, T. Urakami, S.A. Weinzimer, M. Phillip, Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42, 1593–1603 (2019). https://doi.org/10.2337/dci19-0028CrossRefPubMedPubMedCentral

27.

J.O. Jeppsson, U. Kobold, J. Barr, A. Finke, W. Hoelzel, T. Hoshino, K. Miedema, A. Mosca, P. Mauri, R. Paroni, L. Thienpont, M. Umemoto, C. Weykamp, Approved IFCC reference method for the measurement of HbA1c in human blood. Clin. Chem. Lab. Med. 40, 78–89 (2002). https://doi.org/10.1515/CCLM.2002.016CrossRefPubMed

28.

J. Villar, L. Cheikh Ismail, C.G. Victora, E.O. Ohuma, E. Bertino, D.G. Altman, A. Lambert, A.T. Papageorghiou, M. Carvalho, Y.A. Jaffer, M.G. Gravett, M. Purwar, I.O. Frederick, A.J. Noble, R. Pang, F.C. Barros, C. Chumlea, Z.A. Bhutta, S.H. Kennedy, International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet 384, 857–868 (2014). https://doi.org/10.1016/s0140-6736(14)60932-6CrossRefPubMed

29.

C. Chen, F.C. Lu, The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed. Environ. Sci. 17(Suppl), 1–36 (2004).PubMed

30.

A. Arafa, J.Y. Dong, Maternal height and risk of gestational diabetes: a systematic review and meta-analysis. Acta Diabetol. 56, 723–728 (2019). https://doi.org/10.1007/s00592-019-01368-9CrossRefPubMed

31.

G. Zhang, J. Bacelis, C. Lengyel, K. Teramo, M. Hallman, O. Helgeland, S. Johansson, R. Myhre, V. Sengpiel, P.R. Njolstad, B. Jacobsson, L. Muglia, Assessing the causal relationship of maternal height on birth size and gestational age at birth: a mendelian randomization analysis. PLoS Med. 12, e1001865 (2015). https://doi.org/10.1371/journal.pmed.1001865CrossRefPubMedPubMedCentral

32.

B.E. Metzger, L.P. Lowe, A.R. Dyer, E.R. Trimble, U. Chaovarindr, D.R. Coustan, D.R. Hadden, D.R. McCance, M. Hod, H.D. McIntyre, J.J. Oats, B. Persson, M.S. Rogers, D.A. Sacks, Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358, 1991–2002 (2008). https://doi.org/10.1056/NEJMoa0707943CrossRefPubMed

33.

M.A. Abdul-Ghani, D. Tripathy, R.A. DeFronzo, Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29, 1130–1139 (2006). https://doi.org/10.2337/diacare.2951130CrossRefPubMed

34.

G. Bock, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, V. Chandramouli, B.R. Landau, R.A. Rizza, Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis. Diabetes 56, 1703–1711 (2007). https://doi.org/10.2337/db06-1776CrossRefPubMed

35.

R. Retnakaran, Y. Qi, M. Sermer, P.W. Connelly, A.J. Hanley, B. Zinman, The antepartum glucose values that predict neonatal macrosomia differ from those that predict postpartum prediabetes or diabetes: implications for the diagnostic criteria for gestational diabetes. J. Clin. Endocrinol. Metab. 94, 840–845 (2009). https://doi.org/10.1210/jc.2008-2434CrossRefPubMed

36.

Y.B. Esterson, M. Carey, L. Boucai, A. Goyal, P. Raghavan, K. Zhang, D. Mehta, D. Feng, L. Wu, S. Kehlenbrink, S. Koppaka, P. Kishore, M. Hawkins, Central regulation of glucose production may be impaired in type 2 diabetes. Diabetes 65, 2569–2579 (2016). https://doi.org/10.2337/db15-1465CrossRefPubMedPubMedCentral

37.

S. Han, P. Middleton, E. Shepherd, E. Van Ryswyk, C.A. Crowther, Different types of dietary advice for women with gestational diabetes mellitus. Cochrane Database Syst. Rev. 2, CD009275 (2017). https://doi.org/10.1002/14651858.CD009275.pub3CrossRefPubMed

38.

J.M. Yamamoto, J.E. Kellett, M. Balsells, A. Garcia-Patterson, E. Hadar, I. Sola, I. Gich, E.M. van der Beek, E. Castaneda-Gutierrez, S. Heinonen, M. Hod, K. Laitinen, S.F. Olsen, L. Poston, R. Rueda, P. Rust, L. van Lieshout, B. Schelkle, H.R. Murphy, R. Corcoy, Gestational diabetes mellitus and diet: a systematic review and meta-analysis of randomized controlled trials examining the impact of modified dietary interventions on maternal glucose control and neonatal birth weight. Diabetes Care 41, 1346–1361 (2018). https://doi.org/10.2337/dc18-0102CrossRefPubMed

39.

N. Foussard, S. Cambos, P. Poupon, M. Monlun, L. Blanco, M. Haissaguerre, V. Grouthier, F.L. Velayoudom-Cephise, K. Mohammedi, V. Rigalleau, Comment on Law et al. suboptimal nocturnal glucose control is associated with large for gestational age in treated gestational diabetes mellitus. Diabetes Care 42, 810–815 (2019). https://doi.org/10.2337/dc19-0446. Diabetes Care 42, e122 (2019)CrossRef

40.

L.C. Gormsen, E. Sondergaard, N.L. Christensen, K. Brosen, N. Jessen, S. Nielsen, Metformin increases endogenous glucose production in non-diabetic individuals and individuals with recent-onset type 2 diabetes. Diabetologia 62, 1251–1256 (2019). https://doi.org/10.1007/s00125-019-4872-7CrossRefPubMed

41.

M.M. Christensen, K. Hojlund, O. Hother-Nielsen, T.B. Stage, P. Damkier, H. Beck-Nielsen, K. Brosen, Endogenous glucose production increases in response to metformin treatment in the glycogen-depleted state in humans: a randomised trial. Diabetologia 58, 2494–2502 (2015). https://doi.org/10.1007/s00125-015-3733-2CrossRefPubMed

42.

J.F. Plows, J.L. Stanley, P.N. Baker, C.M. Reynolds, M.H. Vickers, The pathophysiology of gestational diabetes mellitus. Int. J. Mol. Sci. 19 (2018). https://doi.org/10.3390/ijms19113342

43.

J. Pedersen, Diabetes mellitus and pregnancy: present status of the hyperglycaemia-hyperinsulinism theory and the weight of the newborn baby. Postgrad. Med. J. Suppl:66–67 (1971).

44.

A. Helman, A.L. Cangelosi, J.C. Davis, Q. Pham, A. Rothman, A.L. Faust, J.R. Straubhaar, D.M. Sabatini, D.A. Melton, A nutrient-sensing transition at birth triggers glucose-responsive insulin secretion. Cell Metab. 31, 1004–1016 e1005 (2020). https://doi.org/10.1016/j.cmet.2020.04.004CrossRefPubMedPubMedCentral

45.

S.M. Schussler-Fiorenza Rose, K. Contrepois, K.J. Moneghetti, W. Zhou, T. Mishra, S. Mataraso, O. Dagan-Rosenfeld, A.B. Ganz, J. Dunn, D. Hornburg, S. Rego, D. Perelman, S. Ahadi, M.R. Sailani, Y. Zhou, S.R. Leopold, J. Chen, M. Ashland, J.W. Christle, M. Avina, P. Limcaoco, C. Ruiz, M. Tan, A.J. Butte, G.M. Weinstock, G.M. Slavich, E. Sodergren, T.L. McLaughlin, F. Haddad, M.P. Snyder, A longitudinal big data approach for precision health. Nat Med. 25, 792–804 (2019). https://doi.org/10.1038/s41591-019-0414-6CrossRefPubMed

46.

E. Herrera, C. Munoz, P. Lopez-Luna, P. Ramos, Carbohydrate-lipid interactions during gestation and their control by insulin. Braz. J. Med. Biol. Res. 27, 2499–2519 (1994).PubMed

47.

E. Larque, A. Pagan, M.T. Prieto, J.E. Blanco, A. Gil-Sanchez, M. Zornoza-Moreno, M. Ruiz-Palacios, A. Gazquez, H. Demmelmair, J.J. Parrilla, B. Koletzko, Placental fatty acid transfer: a key factor in fetal growth. Ann. Nutr. Metab. 64, 247–253 (2014). https://doi.org/10.1159/000365028CrossRefPubMed

48.

T. Radaelli, J. Lepercq, A. Varastehpour, S. Basu, P.M. Catalano, S. Hauguel-De Mouzon, Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus. Am. J. Obstet. Gynecol. 201, 209 e201–209 e210 (2009). https://doi.org/10.1016/j.ajog.2009.04.019CrossRef

49.

K.A. West, C. Kanu, T. Maric, J.A.K. McDonald, J.K. Nicholson, J.V. Li, M.R. Johnson, E. Holmes, M.D. Savvidou, Longitudinal metabolic and gut bacterial profiling of pregnant women with previous bariatric surgery. Gut 69, 1452–1459 (2020). https://doi.org/10.1136/gutjnl-2019-319620CrossRefPubMed

50.

A. Ceriello, L. Monnier, D. Owens, Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 7, 221–230 (2019). https://doi.org/10.1016/S2213-8587(18)30136-0CrossRefPubMed

51.

M. Gauster, A. Majali-Martinez, S. Maninger, E. Gutschi, P.H. Greimel, M. Ivanisevic, J. Djelmis, G. Desoye, U. Hiden, Maternal Type 1 diabetes activates stress response in early placenta. Placenta 50, 110–116 (2017). https://doi.org/10.1016/j.placenta.2017.01.118CrossRefPubMed

52.

D. Schneider, C. Hernandez, M. Farias, R. Uauy, B.J. Krause, P. Casanello, Oxidative stress as common trait of endothelial dysfunction in chorionic arteries from fetuses with IUGR and LGA. Placenta 36, 552–558 (2015). https://doi.org/10.1016/j.placenta.2015.02.003CrossRefPubMed

Titel: Identification of maternal continuous glucose monitoring metrics related to newborn birth weight in pregnant women with gestational diabetes
verfasst von: Song-Ying Shen
Justina Žurauskienė
Dong-Mei Wei
Nian-Nian Chen
Jin-Hua Lu
Ya-Shu Kuang
Hui-Hui Liu
Jean-Baptiste Cazier
Xiu Qiu
Publikationsdatum: 14.06.2021
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 2/2021
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-021-02787-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Serum secreted frizzled-related protein 5 in relation to insulin sensitivity and its regulation by insulin and free fatty acids

Cytology versus calcitonin assay in fine-needle aspiration biopsy wash-out fluid (FNAB-CT) in diagnosis of medullary thyroid microcarcinoma

A diffuse pruriginous erythemato-squamous rash

Association of triglyceride–glucose index with intra- and extra-cranial arterial stenosis: a combined cross-sectional and longitudinal analysis

A rare metanephrine–predominant secretion phenotype of paraganglioma challenged an interpretation of imaging localization

Extending the endocrine hypertension spectrum: novel nonclassic apparent mineralocorticoid excess